JAG1 Variants Confer Genetic Susceptibility to Thyroid Dysgenesis and Thyroid Dyshormonogenesis in 813 Congenital Hypothyroidism in China
Miaomiao Li,Xiaoyu Wang,Fang Wang,Fengqi Wang,Dehua Zhao,Shiguo Liu
DOI: https://doi.org/10.2147/ijgm.s445557
IF: 2.145
2024-03-08
International Journal of General Medicine
Abstract:Miaomiao Li, 1, 2 Xiaoyu Wang, 1, 2 Fang Wang, 3 Fengqi Wang, 1, 2 Dehua Zhao, 4 Shiguo Liu 1, 2 1 Department of Medical Genetic, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 2 Prenatal Diagnosis Center, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 3 Endocrinology Department, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 4 Neonatal Screening Center, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China Correspondence: Dehua Zhao, The Third Affiliated Hospital of Zhengzhou University, Neonatal Screening Center, Zhengzhou, Henan, 450052, People's Republic of China, Email Shiguo Liu, The Affiliated Hospital of Qingdao University, Department of Medical Genetic, Prenatal Diagnosis Center, Qingdao, Shandong, 266003, People's Republic of China, Email Background and Objective: Congenital hypothyroidism (CH) is indeed a prevalent neonatal endocrine disorder, affecting approximately 1 in 2000– 3000 newborns worldwide, and 1 in 2400 newborns in China. Despite its high incidence, the genetic causes of CH, particularly those related to thyroid dysgenesis (TD), are still not well understood. However, previous studies have suggested that JAG1 may be a potential susceptibility gene for congenital thyroid defects. To explore the association between JAG1 and CH, we screened JAG1 variants in a large cohort of 813 CH patients. Methods: We performed genetic analysis of JAG1 using next-generation sequencing in 813 CH cases. The pathogenicity of the variants was assessed by bioinformatics softwares, protein sequence conservation analysis, and hydrophobic analysis. Further genetic analysis was conducted targeting 20 CH-related genes in these 25 JAG1 variant carriers. Results: We identified 10 pathogenic missense mutations (p.V45L, p.V272I, p.P552L, p.G610E, p.G852D, p.A891T, p.E1030K, p.R1060W, p.A1131T, p.P1174L) carried by 25 patients, the mutation rate of JAG1 in CH was 3.08%. Among these 25 patients, 16 with 1 variant, 6 with 2 variants, and the other 3 with 3 variants. Our findings indicated that JAG1 variants confer genetic susceptibility to both TD and DH, but with different inheritance models. JAG1 variants lead to TD mainly through monogenic model, while for DH cases, both monogenic mechanisms and oligogenic mechanisms play a pivotal role. Oligogenicity may contribute to the disease severity of DH. Conclusion: JAG1 is a shared genetic factor in TD and DH, with a detection rate of 3.08% in Chinese individuals with CH. A comparison between the oligogenic and monogenic groups suggests a gene dosage effect in CH. Patients with the same JAG1 mutation exhibit diverse clinical phenotypes, indicating complex mechanisms underlying phenotypic heterogeneity. Keywords: congenital hypothyroidism, JAG1 , pathogenic variant, inheritance model, phenotypic heterogeneity Congenital hypothyroidism (CH) characterized by primary thyroid hormone deficiency, is the most common and preventable neonatal endocrine disorder, with an incidence of 1 in 2000–3000 newborns worldwide, and 1 in 2400 in China. 1,2 Extensive research in human and experimental models has confirmed the genetic origin of CH. 3 CH can be classified into two groups based on the pathogenesis: dyshormonogenesis (DH) and thyroid dysgenesis (TD). DH is associated with genes such as DUOX2, DUOXA2, DUOX1, IYD, SLC5A5, TG, TPO, SLC26A4 , and SLC26A7 , which are inherited in an autosomal-recessive manner. 4 In contrast, the pathogenesis of TD is more complex, with well-established pathogenic genes including NKX2.1, PAX8, TSHR , and FOXE1 . Next-generation sequencing has led to the identification of additional candidate genes for TD, such as NKX2.5, GLIS3, CDCA8, NTN1, TUBB1, THRB, NNT, DUOX2, and JAG1 . 5,6 TD caused by these genetic defects can occur in isolation or in conjunction with extrathyroidal abnormalities, but the risk is significantly higher in the context of syndromes. Therefore, exploring TD pathogenesis from the perspective of syndromic TD pathogenic genes may be a more efficient strategy. JAG1 (NM_000214.3) is located on human chromosome 20p12.2 and encodes a ligand of the Notch signaling pathway. It is expressed on the cell surface and activates Notch signaling by interacting with receptors on adjacent cells. Defects in JAG1 have been identified as the main cause of Alagille syndrome (ALGS; OMIM 118450), a mul -Abstract Truncated-
medicine, general & internal